menu
    • menu

    Company profile for FibroBiologics

    NEW Drugs in Dev: 4
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    FibroBiologics is a pioneering biopharmaceutical company specializing in the development and distribution of fibroblast cell-based therapies for patients with chronic illnesses. Our exclusive fibroblast platform forms the basis for creating biological cures and remedies for various chronic conditions, spanning from degenerative disc disease and multiple sclerosis to wound healing and cancer. Additionally, we explore applicatio...
    FibroBiologics is a pioneering biopharmaceutical company specializing in the development and distribution of fibroblast cell-based therapies for patients with chronic illnesses. Our exclusive fibroblast platform forms the basis for creating biological cures and remedies for various chronic conditions, spanning from degenerative disc disease and multiple sclerosis to wound healing and cancer. Additionally, we explore applications for extending life and reversing age-related declines, such as thymic involution and splenic involution.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    FibroBiologicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Houston, TX 77598
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://fibrobiologics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/fibrobiologics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FibroBiologics Doses First Patients in CYWC628 Phase 1/2 Trial
    FibroBiologics Doses First Patients in CYWC628 Phase 1/2 Trial

    03 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/03/3305903/0/en/fibrobiologics-announces-first-patients-dosed-in-phase-1-2-clinical-trial-evaluating-cywc628-for-the-treatment-of-diabetic-foot-ulcers.html

    GLOBENEWSWIRE
    03 Jun 2026
    Share Share
    FibroBiologics Presents Psoriasis Data at SID 2026
    FibroBiologics Presents Psoriasis Data at SID 2026

    22 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/22/3300109/0/en/fibrobiologics-presents-preclinical-data-demonstrating-durable-immunomodulation-in-psoriasis-at-the-society-for-investigative-dermatology-2026-annual-meeting.html

    GLOBENEWSWIRE
    22 May 2026
    Share Share
    FibroBiologics Files Patent for Oral Fibroblast Therapeutics
    FibroBiologics Files Patent for Oral Fibroblast Therapeutics

    18 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/18/3296634/0/en/fibrobiologics-files-patent-application-for-oral-administration-of-fibroblast-therapeutics.html

    GLOBENEWSWIRE
    18 May 2026
    Share Share
    FibroBiologics Advances Fibroblast Therapy for Hantavirus
    FibroBiologics Advances Fibroblast Therapy for Hantavirus

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3291882/0/en/fibrobiologics-advancing-development-of-a-fibroblast-treatment-for-hantavirus.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Fibrobiologics CEO Issues Letter To Shareholders
    Fibrobiologics CEO Issues Letter To Shareholders

    05 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7271202

    FIRSTWORD PHARMA
    05 May 2026
    Share Share
    FibroBiologics Releases CYWC628 for Phase 1/2 DFU Trial
    FibroBiologics Releases CYWC628 for Phase 1/2 DFU Trial

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286693/0/en/fibrobiologics-announces-release-of-cywc628-drug-product-for-phase-1-2-diabetic-foot-ulcer-clinical-trial.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search